Bronchiectasis. Grant Waterer. Professor of Medicine, University of Western Australia Adjunct Professor of Medicine, Northwestern University, Chicago

Similar documents
NON-CYSTIC FIBROSIS BRONCHIECTASIS

Non-CF bronchiectasis: Alexander Duarte, MD Pulmonary, Critical Care & Sleep Medicine University of Texas Medical Branch Galveston, TX

Corporate Medical Policy

Bronchiectasis. What is bronchiectasis? What causes bronchiectasis?

Overview of Cystic fibrosis in children. Apeksha Sathyaprasad, MD Pediatric pulmonologist

National Horizon Scanning Centre. Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis. April 2008

Dr Conroy Wong. Professor Richard Beasley. Dr Sarah Mooney. Professor Innes Asher

Cystic Fibrosis: Progress in Treatment Management. Patrick A. Flume, M.D. Medical University of South Carolina

Bronchiectasis. Introduction. Key points

CCLI. Bronchiectasis Treatment Antibiotics. Charles Haworth. Physician / Patient Conference, Georgetown University, May 2017

Management of bronchiectasis in adults

FEP Medical Policy Manual

Update on bronchiectasis guidelines. James Chalmers MD, PhD, FRCPE, FERS University of Dundee, UK

acapella vibratory PEP Therapy System Maximizing Therapy Effectiveness, Empowering Patient Compliance

Bronchiectasis. Examples include: Viral infections (measles, adenovirus, influenza)

What is Cystic Fibrosis? CYSTIC FIBROSIS. Genetics of CF

NON-CF BRONCHIECTASIS IN ADULTS

Inhaled Antibiotics in Non-CF. Dr Michael Loebinger Host Defence Unit Royal Brompton Hospital London, United Kingdom

COPD Treatable. Preventable.

Protocol. Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions

Acapella versus usual airway clearance during acute exacerbation in bronchiectasis: a randomized crossover trial

LRI Children s Hospital

REFERRAL GUIDELINES RESPIRATORY

Inhalational antibacterial regimens in non-cystic fibrosis patients. Jeff Alder Bayer HealthCare

Bronchiectasis in Adults - Suspected

Physiotherapy in lung disease - top tips for clinicians. Sita Kansagra Specialist Outpatient Physiotherapist

A Place For Airway Clearance Therapy In Today s Healthcare Environment

Sputum, Gotta Love The Stuff!

High Frequency Chest Wall Oscillation Devices

Physiotherapy treatment in cystic fibrosis: airway clearance techniques. Factsheet March Fighting for a

Cystic Fibrosis the future

Appendix D Clinical specialist statement template

Northumbria Healthcare NHS Foundation Trust. Bronchiectasis. Issued by Respiratory Medicine

Goals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy

Marcos I. Restrepo, MD, MSc, FCCP

Bronchiectasis it s effects on the NZ population and what we can do to address this

Bronchiectasis. Information for patients Therapy Services - Surgical

International Journal of Health Sciences and Research ISSN:

High Frequency Chest Wall Oscillating Devices (HFCWO) (Airway Clearance Systems)

Bronchiectasis exacerbations; differences and management. Michael Loebinger Royal Brompton Imperial College

CYSTIC FIBROSIS INPATIENT PROTOCOL PURPOSE POLICY STATEMENTS SITE APPLICABILITY PRACTICE LEVEL/COMPETENCIES DEFINITIONS EQUIPMENT

Non-cystic fibrosis bronchiectasis

Non Cystic Fibrosis Bronchiectasis: How to Proceed?

Intracheal antibiotics administration

INHALED ANTIBIOTICS THERAPY IN NON-CF LUNG DISEASE

Positive Expiratory pressure (PEP), Acapella and Flutter

Active Cycle of Breathing Technique

THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable

The Importance of Appropriate Treatment of Chronic Bronchitis

The objectives of this presentation are to

JUERGEN FROEHLICH, JANICE DAHMS, DAVID CIPOLLA,

11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad.

CYSTIC FIBROSIS OBJECTIVES NO CONFLICT OF INTEREST TO DISCLOSE

Is Physiotherapy routinely required following video-assisted thoracoscopic surgery (VATS)?

Chronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines

Guideline for the Diagnosis and Management of COPD

Clinical Commissioning Policy Proposition: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)

Over the last several years various national and

Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions

PORT CFNZ National Data Registry ~ 1 ~

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Background. Background. Background 3/14/2014. Conflict of Interest Statement:

THE WINSTON CHURCHILL MEMORIAL TRUST OF AUSTRALIA. Report by Jamie Wood BSc. (Physiotherapy) Churchill Fellow

Airway Vista Background

Historical perspective

62 year old man with a cough! Dr. Aflah Sadikeen Consultant Respiratory Physician Colombo

TITLE: Hypertonic Saline Nebules for Patients with Cystic Fibrosis and Bronchioectasis: A Review of the Clinical and Cost-Effectiveness

WF RESPIRATORY SYSTEM. RESPIRATORY MEDICINE

Respiratory Care and Cystic Fibrosis. David E Geller MD and Bruce K Rubin MEngr MD MBA FAARC

Cystic fibrosis: From childhood to adulthood. Eitan Kerem Department of Pediatrics and CF Center Hadassah University Hospital Jerusalem Israel

Journal Club The ELITE Trial. Sandra Katalinic, Pharmacy Resident University Hospital of Northern British Columbia April 28, 2010

Populations Interventions Comparators Outcomes Individuals: With cystic fibrosis. therapy. therapy

COPD: Preventable and Treatable. Lecture Outline. Diagnosis of COPD. COPD: Defining Terms

C.S. HAWORTH 1, A. WANNER 2, J. FROEHLICH 3, T. O'NEAL 3, A. DAVIS 4, I. GONDA 3, A. O'DONNELL 5

COPD: Current Medical Therapy

Shared Care Guideline

High Frequency Chest Wall Oscillation Devices

Assessing response to treatment of exacerbations of bronchiectasis in adults

Session Guidelines. This is a 15 minute webinar session for CNC physicians and staff

Chronic Obstructive Pulmonary Disease (COPD) Copyright 2014 by Mosby, an imprint of Elsevier Inc.

Disclaimer. Objectives. I can t cough it up! Airway Clearance Therapy. Heather Murgatroyd, RRT, RPSGT Field Clinical Specialist

Nebulised hypertonic saline for cystic fibrosis.

US FDA approved ARIKAYCE (amikacin liposome inhalation suspension) antibacterial drug to treat a serious lung disease approved on 28 th Sept 2018

an inflammation of the bronchial tubes

EZPAP INSTRUCTIONS PDF

Asthma in Day to Day Practice

Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing

Cystic Fibrosis: Pulmonary Exacerbations Management Guidelines

Innovative products for r espiratory rrespiratory d iseases diseases September 2012

Diagnostic Evaluation of NTM and Bronchiectasis

2/12/2015. ASTHMA & COPD The Yin &Yang. Asthma General Information. Asthma General Information

Cystic Fibrosis. Jennifer McDaniel, BS, RRT-NPS

Focus on Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis

Cystic Fibrosis Foundation Patient Registry 2013

BTS Guideline for non-cf Bronchiectasis

The Use of Active Cycle of Breathing Technique (ACBT) In Pulmonary Physiotherapy: A Critical Review of the Literature Lauro G. Villegas Jr.

Respiratory Diseases and Disorders

Bronchiectasis: An Imaging Approach

Pseudomonas aeruginosa eradication guideline

Chapter 22. Pulmonary Infections

Transcription:

Bronchiectasis Grant Waterer MBBS PhD MBA FRACP FCCP Professor of Medicine, University of Western Australia Adjunct Professor of Medicine, Northwestern University, Chicago

Conflicts of Interest I have served on advisory panels for Pharmaxis (Bronchitol) Savara Pharmaceutical (aerovanc) AstraZeneca/GSK/Almirall I will discuss off-label indications of some medications

What is bronchiectasis?

Damaged, enlarged bronchi

Bronchiectasis is a disease with a large spectrum of severity Asymptomatic Disease Classic Severe Disease

How common is bronchiectasis?

Prevalence of Bronchiectasis in the USA from Medicare Claims Database Seitz et al Chest 2012

What causes bronchiectasis?

What causes bronchietasis? Worldwide Tuberculosis is no.1 In Australia don t know is no.1 Atypical mycobacterial infection Childhood pneumonia/severe pneumonia Various immune defects COPD Lung fibrosis (ILD, rheumatoid etc) Many rare causes

Approach to a new patient with bronchiectasis White cell count Immunoglobulins including IgG subclasses and IgE ANA + Rheumatoid factor if hx CTD CF genotype Family history, sinusitis, infertility, Pseudomonas, <30 years onset Mannose binding lectin Alpha-1-antitrypsin? HIV? Sputum cultures Bronchoscopy if suspect NTM Exhaled NO if want to screen for cilial disorders

Non tuberculous mycobactera Women 9x men Anterior segments of RML/lingula Nodules +/- bronchiectasis In men COPD/alcohol overwhelming comorbidities Women almost all post menopausal Strong genetic features Environmental exposure also important

What is going on in bronchiectasis?

Chronic Bacterial Infection Inflammatory Response Remodeling/Fibrosis Suppressed Immune Response

So what can we do about it?

Treatment options Oral antibiotics Macrolide, tetracycline, beta-lactams Inhaled antibiotics Nebulized aminoglycosides Mucolytics Hypertonic/normal saline, NAC, mannitol Non Medical Therapies Physiotherapy/mucus clearance

Treatment pathway PRODUCTIVE COUGH 2/52 Iv AB s ACTIVE CYCLE OF BREATHING (Huff + Puff) + ACAPELLA/FLUTTER Nebulized Gentamicin 80mg bd Or Tobramycin 160mg bd OR DPI Tobramycin Doxycycline 50mg/day Azithromycin 500mg/ 3x week or 250mg/day

Airway Clearance Is Critical Reduce the soup of inflammatory material Reduce the food for bacterial growth Improve ventilation by lung recruitment but I don t want to cough

Airway clearance is critical Basic techniques Active cycle of breathing, huff and puff, percussion, exercise! Humidification And avoidance of dehydration Mechanical Acapella, flutter, PEP +/- oscillation, cough assist, cough vests etc Chemical Mannitol, Hypertonic saline, N-acetyl saline, Beta-2 agonists

Flutter Uses a steel ball to produce oscillations Exhalation through flutter provides a low level of PEP while producing vibrations extending to the chest Advantages: Easy to clean Portable Inexpensive (~$50) Disadvantages: Requires being held horizontally May be heavy for elderly patients

Acapella A flow operated oscillatory PEP device Uses a counterweighted plug and magnet Green expiratory flows of >15 L/minute Blue expiratory flows <15L/minute (not available at NMH) Advantages: Able to vary amount of PEP included (resistance dial on tail) May use in any position Lighter then Flutter Inexpensive (~$50) Disadvantages: Harder to clean Larger than flutter

Exacerbation rate/year 3 Macrolide RCT s 2.5 2 1.5 1 Drug Placebo 0.5 0 BLESS BAT EMBRACE

Azithromycin responders Han et al Am J Respir Crit Care Med 2014 Sub-analysis of the Albert et al NEJM 2011 Time to first exacerbation Smoking negated a benefit HR 0.65 ex-smokers, HR 0.99 current smokers Chronic bronchitis no impact on effect HR 0.76 (0.62-0.94) CB+ HR 0.64 (0.52-0.80) CB-

Doxycycline is a simpler treatment to start with if you don t have Pseudomonas Intermittent high dose amoxycillin also has some evidence

Nebulised antibiotics if you do have Pseduomonas and lots of exacerbations

Drug companies are finally interested in bronchiectasis!

Inhaled antibiotics in trials Ciprofloxacin DPI Liposomal ciprofloxacin Levofloxacin DPI Vancomycin DPI + nebulisation Amikacin nebulisation Aztreonam nebulisation Tobramycin DPI + nebulisation Fosfomycin/Tobramycin nebulisation Colistin DPI + nebulisation

What the don t tell you in the text books You can t run a bronchiectasis service without a good physiotherapist (respiratory therapist) Urinary incontinence Physiotherapy Uro/Gynae review Codeine for social events Always ask could this be surgically resected